We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSA
5276
VisionSys AI
VSA
$10.6M
0
VIVS
5277
VivoSim Labs
VIVS
$1.64M
$1K ﹤0.01%
8
-70
-90% -$7.04K
AUMN
5278
DELISTED
Golden Minerals Company
AUMN
$1K ﹤0.01%
60
-218
-78% -$3.88K
LUMO
5279
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1K ﹤0.01%
123
-115
-48% -$1.28K
LEV.WS
5280
DELISTED
The Lion Electric Company Redeemable Warrants, each whole warrant entitles the holder to purchase one Common Share at a price of $11.50 per share
LEV.WS
$1K ﹤0.01%
+137
New +$852
ASTSW
5281
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$1K ﹤0.01%
+182
New +$572
VLD
5282
DELISTED
Velo3D, Inc.
VLD
$1K ﹤0.01%
3
-346
-99% -$123K
CNTG
5283
DELISTED
Centogene N.V. Common Shares
CNTG
$1K ﹤0.01%
55
-834
-94% -$8.76K
TPHS
5284
DELISTED
Trinity Place Holdings Inc.com
TPHS
$1K ﹤0.01%
319
AONC
5285
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$1K ﹤0.01%
+100
New +$979
SCX
5286
DELISTED
The L.S. Starrett Company
SCX
$1K ﹤0.01%
+140
New +$1.1K
CMLS
5287
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$1K ﹤0.01%
41
-3,708
-99% -$39.2K
NURO
5288
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$1K ﹤0.01%
+52
New +$1.33K
ARRWU
5289
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
$1K ﹤0.01%
+56
New +$559
BPTH
5290
DELISTED
Bio-Path Holdings Inc
BPTH
$1K ﹤0.01%
+10
New +$1.23K
VHAQ.U
5291
DELISTED
Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
$1K ﹤0.01%
140
-1,039
-88% -$10.8K
CHIC
5292
DELISTED
Global X MSCI China Communication Services ETF
CHIC
$1K ﹤0.01%
35
PRSRU
5293
DELISTED
Prospector Capital Corp. Unit
PRSRU
$1K ﹤0.01%
134
IBTD
5294
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
$1K ﹤0.01%
25
+6
+32% +$154
EQRX
5295
DELISTED
EQRx, Inc. Common Stock
EQRX
$1K ﹤0.01%
+76
New +$778
DKDCU
5296
DELISTED
Data Knights Acquisition Corp. Unit
DKDCU
$1K ﹤0.01%
+50
New +$508
AAC.U
5297
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$1K ﹤0.01%
+100
New +$1K
BOAC
5298
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$1K ﹤0.01%
+131
New +$1.3K
KLR
5299
DELISTED
Kaleyra, Inc.
KLR
$1K ﹤0.01%
30
-812
-96% -$36.6K
EBET
5300
DELISTED
EBET, INC. Common Stock
EBET
$1K ﹤0.01%
+2
New +$1.32K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.